Analysis on clinical features and prognosis of patients with uterine corpus rhabdomyosarcoma base on SEER database
10.3969/j.issn.1671-8348.2024.22.002
- VernacularTitle:基于SEER数据库分析子宫体横纹肌肉瘤患者的临床特征及预后
- Author:
Hao HE
1
;
Xin CHENG
;
Hongbing CAI
Author Information
1. 武汉大学中南医院妇科肿瘤科,武汉 430062
- Keywords:
rhabdomyosarcoma;
uterine corpus rhabdomyosarcoma;
prognosis;
SEER database
- From:
Chongqing Medicine
2024;53(22):3367-3374
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical pathological characteristics,treatment methods and prognosis of the patients with uterine corpus rhabdomyosarcoma(UcRMS).Methods The data from 237 pa-tients with UcRMS during 2000-2020 were retrospectively collected from the Surveillance,Epidemiology and End Results(SEER)database.The descriptive statistical method was employed to conduct the descriptive a-nalysis on clinicopathological characteristics and prognosis of UcRMS patients.The Kaplan-Meier method was adopted to conduct the survival analysis on the patients with different pathological types and treatment meth-ods,and draw the survival curve.The Log-rank test was employed to compare the survival analyses.The uni-variate and multivariate Cox regression were performed to analyze the independent factors affecting the prog-nosis of UcRMS patients.Results Among histologically confirmed cases,the most common type was embry-onic type(44 cases,18.6%)and followed by the pleomorphic type(35 cases,14.8%).In terms of treatment,21 cases(8.9%)received the surgery combined with chemotherapy and radiotherapy(surgery+chemotherapy+radiotherapy).75 cases(31.6%)received the surgery+chemotherapy,and 23 cases(9.7%)received the sur-gery+radiotherapy.The median overall survival(OS)time in the cohorts was 13 months,the median cancer-related survival(CSS)was 14 months,the 5-year OS rate and CSS rate were only 16%.The OS rate and CSS rate for embryonic type RMS were significantly better than those for the undefined and other pathological types,with statistically significant differences(P<0.001).In terms of treatment,the OS rate and CSS rate in the surgery+chemotherapy+radiotherapy group were superior to those in the surgery+chemotherapy group and surgery+radiotherapy group,with statistically significant differences(P=0.011,P=0.012).The histological type,stage,surgery and chemotherapy were the factors affecting the OS time and CSS time of the patients(P<0.05,P<0.001).Conclusion The prognosis of embryonic type UcRMS is better than that of other histological types,but the overall prognosis is still poor,the 5-year survival rate is less than 20%.The histological type,stage,surgery and chemotherapy are the important influencing factors of prognosis,and the surgery+chemotherapy+radiotherapy could improve the prognosis of UcRMS patients.